Literature DB >> 1637086

Membrane actions of calcitonin gene-related peptide in cardiac and smooth muscle myocytes.

H A Tritthart1, U Stark, G Stark, W Mahnert, C O Stender, W Schreibmayer.   

Abstract

Calcitonin gene-related peptide is a 37-amino acid neuropeptide acting as a transmitter of nonadrenergic, noncholinergic nerves in the heart. Binding sites of high affinity have been reported in coronary arteries, in atria, and, of minor density, in ventricular myocardium. These sites are likely linked to G-proteins mediating modifications of ion channel opening probability and duration and to stimulation of adenylate cyclase activity and cAMP-mediated alterations of ion channel activities. In isolated and perfused guinea pig hearts, low concentrations of CGRP (1-3 nM) exerted no chronotropic effect, but increased coronary flow slightly. Atrioventricular conduction duration and effective refractory period of atrioventricular conduction were prolonged by 3 nM of CGRP. The higher concentration of 10 nM increased the sinus rate, and the effects on the atrioventricular node were counterbalanced. HV and QRS duration of the ECG remained essentially unchanged, but persistent ventricular fibrillation was inducible by burst stimulation in all CGRP-treated hearts. Results in human myometrial myocytes indicate that CGRP exerted direct G protein-mediated activation of potassium channels, leading to hyperpolarization and smooth muscle relaxation. Activation of potassium channels, most prominent in smooth muscle relaxation, is likely an additional factor in the cardiostimulatory profile of CGRP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1637086     DOI: 10.1111/j.1749-6632.1992.tb22770.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  1 in total

1.  Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy.

Authors:  Y L Dong; L Fang; S Kondapaka; P R Gangula; S J Wimalawansa; C Yallampalli
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.